$100,000 grant provided to Nai-Kong V. Cheung, MD, of Memorial Sloan Kettering
TeamConnor is proud to announce a $100,000 grant provided to Nai-Kong V. Cheung, MD, PhD to fund the final phase of his drug development on bispecific T-Cell Engaging Antibody to target neuroblastoma. This award will allow Dr. Cheung and his team to begin study initiation by using the drug on patients for the first time, bridging the gap between lab and the patient, which should begin in early 2012. Memorial Sloane Kettering is consistently ranked as one of the nation’s top cancer centers by U.S. News & World Report.




